C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,779 | -61.6% | 12,350 | -27.8% | 0.02% | -60.4% |
| Q4 2022 | $100,902 | -40.3% | 17,102 | -11.4% | 0.05% | -20.9% |
| Q3 2022 | $169,000 | +16.6% | 19,305 | +0.7% | 0.07% | +24.1% |
| Q2 2022 | $145,000 | +13.3% | 19,169 | +263.4% | 0.05% | -5.3% |
| Q1 2022 | $128,000 | -28.9% | 5,275 | -5.6% | 0.06% | -16.2% |
| Q4 2021 | $180,000 | -20.0% | 5,589 | +10.8% | 0.07% | -31.3% |
| Q3 2021 | $225,000 | +11.9% | 5,043 | -5.1% | 0.10% | +19.3% |
| Q2 2021 | $201,000 | – | 5,312 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |